Monitor Aurora's response and any defensive tactics (poison pill, asset sales). The 105-day tender period and lack of financing condition suggest Curaleaf is committed, but the deal is not yet formal. Watch for Aurora shareholder reaction and potential competing bids.
Price Chart
Executive Summary
Curaleaf announced its intention to launch a hostile take-over bid for Aurora Cannabis, offering US$4.00 per share (45% premium to Aurora's 30-day VWAP) in a mix of stock and cash. The bid is unsolicited after Aurora's board refused to engage, and Curaleaf is going directly to shareholders. No formal bid has commenced and there is no assurance it will be made, but the public pressure campaign signals a significant M&A escalation in the global cannabis sector.
Key Facts
- Curaleaf announced intention to launch a take-over bid for all outstanding shares of Aurora Cannabis Inc.
- Offer consideration is US$4.00 per Aurora share: 0.3463 Curaleaf shares + US$0.75 cash.
- Implied premium of 45% over Aurora's 30-day VWAP of US$2.75; 110% premium excluding Aurora's cash.
- Combined company would have >US$1.5 billion LTM revenue and nearly US$350 million LTM Adjusted EBITDA.
- Curaleaf expects at least US$40 million in annual cost synergies.
- Aurora's board refused to engage after letters dated June 23 and July 7, 2026.
- Offer will be open for 105 days; no due diligence or financing conditions.
- No formal take-over bid has been commenced; there is no assurance the offer will ultimately be made.
Financial Impact
Combined pro forma market cap approaching US$3.0 billion; at least US$40 million annual cost synergies expected
Risk Factors
- Aurora may adopt defensive measures (shareholder rights plan, asset sales) that could block or delay the bid.
- Curaleaf's stock price decline could reduce the value of the share consideration, making the offer less attractive.
- Regulatory hurdles in multiple jurisdictions (Canada, US, EU) could complicate or prevent the transaction.
- No formal bid has been commenced; Curaleaf may walk away if material adverse information surfaces.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-056012 |
| Document: a2026-08x11xcuraleafxann.htm | 0001628280-26-056012 |
| Document: 0001628280-26-056012-index-headers.html | 0001628280-26-056012 |
| Document: 0001628280-26-056012-index.html | 0001628280-26-056012 |
| Document: 0001628280-26-056012.txt | 0001628280-26-056012 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 today | 8-K / 425 | $8.57 | awaiting T+5 | awaiting T+5 | $8.48 (−1.05%) |
Oct 19, 2026 9d ago | 425 / 8-K | $7.86 $8.29 | ▲ +5.47% | ▲ +5.44% | $8.48 (+7.89%) |
Oct 6, 2026 22d ago | 425 | $9.99 $8.82 | ▼ −11.71% | ▼ −11.57% | $8.48 (−15.12%) |
Oct 6, 2026 22d ago | 8-K | $9.99 $8.82 | ▼ −11.71% | ▼ −11.57% | $8.48 (−15.12%) |
Oct 6, 2026 22d ago | 425 | $9.99 $8.82 | ▼ −11.71% | ▼ −11.57% | $8.48 (−15.12%) |
Oct 6, 2026 22d ago | 8-K | $9.99 $8.82 | ▼ −11.71% | ▼ −11.57% | $8.48 (−15.12%) |
Oct 1, 2026 27d ago | 8-K | $9.95 $9.39 | ▼ −5.63% | ▼ −6.79% | $8.48 (−14.77%) |
Oct 1, 2026 27d ago | 8-K | $9.95 $9.39 | ▼ −5.63% | ▼ −6.79% | $8.48 (−14.77%) |
Sep 16, 2026 6w ago | 8-K | $9.98 $11.62 | ▲ +16.43% | ▲ +13.60% | $8.48 (−15.03%) |
Sep 16, 2026 6w ago | 425 | $9.98 $11.90 | ▲ +19.24% | ▲ +17.16% | $8.48 (−15.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers